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Background and purpose   Drainage after surgery is commonly 
used, and the contents are generally discarded as clinical waste. 
We analyzed closed suction drainage fluid from hip arthroplasty 
patients to determine whether any multipotent stem cells were 
present that could be used as a source of cells for tissue regenera-
tion.
Methods   Drainage fluid was obtained from 14 patients after 
hip arthroplasty on the day of surgery, the next day, and 2 days 
after surgery. Peripheral blood and bone marrow from the iliac 
crest were also obtained from the same patients during surgery. 
These samples were examined using regular flow cytometric pro-
filing, and we performed quantitative immunoassays of stromal-
derived factor-1 (SDF1) levels in the plasma. Mononuclear cells 
(MNCs) from these samples were also isolated and cultured. 
Fibroblastic adherent cells from MNC fractions were cultured 
in an osteogenic and a chondrogenic differentiation medium and 
were then evaluated for multipotentency.
Results and interpretation   Fibroblastic adherent cells were 
isolated from the mononuclear cell fraction of bone marrow and 
drainage fluid on the day of surgery, but they were not present in 
either the mononuclear cell fraction of the peripheral blood or the 
drainage fluid on the next day and 2 days after surgery. The cells 
from the drainage fluid on the day of surgery could differentiate 
in vitro into osteogenic and chondrogenic cells. SDF1 was elevated 
on the day of surgery, while CXCR4 was elevated on that day 
and the next day. This suggests that locally-induced SDF1 con-
tributes to the mobilization of circulating CXCR4-positive cells. 
These results show that the drainage fluid collected on the day 
of surgery contains stem/progenitor cells that could be used for 
autologous cell-based therapy.
 
Stem cells are vitally involved in tissue regeneration and 
homeostasis. Mesenchymal stem cells (MSCs) have the 
potential to differentiate into lineages of mesenchymal tis-
sues, including cartilage, bone, fat, and muscle. Isolation and 
characterization of MSCs from bone marrow, muscle, adipose 
tissue, or synovial tissue have been reported (Pittenger et al. 
1999, Lee et al. 2000, De Bari et al. 2001, Jones et al. 2002, 
Gimble et al. 2007).
The clinical use of MSCs is increasing, with profound 
implications for regenerative medicine. Several animal studies 
have demonstrated the efficacy of using stem cells in the treat-
ment of bone defects (Ohgushi et al. 1989, Bruder et al. 1994, 
Ranieri et al. 2007, Veronique et al. 2007). Local injection 
of ex vivo expanded autologous bone marrow stem cells has 
been used successfully for the treatment of large bone defects 
in 3 patients (Quarto et al. 2001). Furthermore, with tissue 
engineering, a titanium-mesh scaffold filled with bone min-
eral blocks infiltrated with BMP7 and a bone marrow mixture 
were found to produce a large amount of bone tissue needed 
for reconstructing a mandibular defect in a patient (Warnke et 
al. 2004).
Drainage fluid connected to a cell-collecting device has 
been used for salvage of red blood cells to re-infuse after 
arthroplasty (Semkiw et al. 1989). White blood cells, includ-
ing the MSC fraction, were usually discarded as clinical waste.
Stromal-derived factor-1 (SDF1) controls many aspects 
of stem cell function (Aiuti et al. 1997, Peled et al. 1999). 
The SDF1/CXCR4 axis plays an essential role in the mobi-
lization and homing of stem/progenitor cells (Ceradini et al. 
2004, Kucia et al. 2005). Furthermore, the expression of SDF1 
is upregulated following irradiation and hypoxia, and SDF1 
can induce the recruitment of endothelial progenitor cells in 
a regeneration model for myocardial infarction (Ceradini et 
al. 2004).Thus, it is of interest to investigate the mechanism 
underlying stem cell recruitment to injured tissues by evaluat-
ing the level of SDF1 or the frequency of CXCR4-positive 
cells in various samples.
We investigated whether the mononuclear cells (MNCs) in 
closed suction drainage fluid after hip arthroplasty could pro-
duce MSCs, and determined the level of SDF1 and frequency 
of CXCR4-positive cells in the drainage fluid to investigate 
the mechanism underlying stem cell recruitment to the injured 
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Materials and methods
Informed consent was obtained from all patients. The research 
methods were reviewed and approved by the committee on 
human ethics of Hiroshima University.
After hip arthroplasty, the closed suction drainage fluid 
from 14 consecutive patients with a mean age of 66 (51–82) 
years was collected on the day of surgery, the next day, and 2 
days after surgery. Peripheral blood and bone marrow from the 
iliac crest were also obtained during the surgery from the same 
patients using EDTA as anticoagulant.
Immunophenotyping of cells
Peripheral blood, bone marrow, and closed suction drain-
age fluid were lysed using an ammonium chloride solution 
(STEMCELL Technologies Inc., Vancouver, Canada) for 10 
min to remove red blood cells from the samples. After lysis 
of the red blood cells, the samples were centrifuged and 
washed twice with phosphate-buffered saline (PBS). The final 
samples were resuspended in 100 μL Hanks’ Balanced Salt 
Solution (HBSS) (GIBCO Laboratories, Grand Island, NY) 
and stained with a combination of CD45-fluorescein isothio-
cyanate (FITC), CD34-phycoerythrin (PE), and CXCR4-allo-
phycocyanin (APC) monoclonal antibodies (BD Biosciences 
Pharmigen, San Diego, CA) for 30 min at 4°C in the dark. 
Thereafter, the samples were washed twice with HBSS and 
resuspended in 500 μL HBSS for flow cytometric profiling 
with a FACSCalibur flow cytometer and the CellQuest soft-
ware program (BD Immunocytometry Systems, Mountain 
View, CA). CXCR4+ cells were identified, and the percentage 
of CXCR4+ cells in MNCs was compared for each sample.
Enzyme-linked immunosorbent assay for SDF1
The concentration of SDF1 in the samples from the last 5 
patients was measured with an enzyme-linked immunosorbent 
assay using a kit (R&D Systems, Minneapolis, MN) according 
to the instructions of the manufacturer.
Isolation and culture of cells
Closed suction drainage fluid was poured into a Leucosep 
227290 (Greiner Bio-One Co. Ltd., Japan) with 15 mL sepa-
ration medium Histopaque 1077 (Sigma-Aldrich, Oakville, 
Canada) and centrifuged at 1,000 g for 10 min. MNCs present 
in the enriched cell fraction were collected and washed twice 
with PBS, and the cell pellet was resuspended in Dulbecco’s 
modified Eagle’s medium (DMEM) (GIBCO Laboratories) 
containing 10% heat-inactivated fetal bovine serum (FBS) 
(Sigma-Aldrich) and antibiotics (penicillin 100 units/mL and 
streptomycin 100 μg/mL). 106 cells were seeded in a 100-mm 
diameter plastic dish and cultured at 37°C in a humidified 
atmosphere containing 5% CO2; the medium was changed on 
a weekly basis. Cell samples were cultured for approximately 
3 weeks after the first seeding. Adherent cells were used in the 
following differentiation assays.
Colony-forming-unit fibroblast assay. The frequency of 
colony-forming-unit fibroblasts (CFU-Fs) was counted after 
culturing the MNCs for approximately 3 weeks in 60-mm 
diameter plastic dishes. The culture dishes were stained with 
Giemsa solution and cell clusters containing > 50 cells were 
scored as CFU-F colonies.
Differentiation of adherent cells. After culturing the MNCs 
for approximately 3 weeks, adherent cells were detached 
using trypsin solution (TrypLE Express, GIBCO) and 104 
cells were seeded and cultured in a 60-mm diameter plastic 
dish for another 3 weeks for osteogenic differentiation using 
osteogenic differentiation medium (Poietics PT-3924; Lonza, 
Walkersville, MD). They were stained with 1% alizarin red 
S to visualize calcium deposition. The calcium content was 
measured using a Stanbio Total Calcium Liquicolor Kit (Stan-
bio Laboratory, Boern, TX). As a control group, additional 
cells were cultured with the standard medium throughout the 
experiment.
To assess chondrogenic differentiation, 2.5 × 105 cells 
were placed in a 15-mL polypropylene tube and pellet cul-
ture was performed (three-dimensional culture) for 3 weeks 
using chondrogenic differentiation medium (TMDFC-001; 
TOYOBO, Japan). The differentiation was evaluated by 
histochemical staining with safranin O. The expression of 
2 chondrocyte-specific genes, those encoding type-II colla-
gen and aggrecan, was assessed by RT-PCR. From the pellet, 
total RNA was isolated using the RNAqueous Micro kit 
(Ambion, Austin, TX). First-strand cDNA was synthesized 
using Superscript III reverse transcriptase (Invitrogen, Carls-
bad, CA) and amplified with Taq DNA polymerase (Amplitaq 
Gold; Applied Biosystems, NJ), according to the manufac-
turer’s instructions. PCR products were analyzed by 1.5% 
agarose gel electrophoresis. The primers used were: human-
specific GAPDH (596 bp): 5’-CTGATGCCCCCATCTTC-
GTC-3’ (forward) and 5’-CACCCTGTTGCTGTAGC-
CAAATTCG-3’ (reverse), human type II collagen (414 bp): 
5’-CTGGCTCCCAACACTGCCAACGTC-3’ (forward) 
and 5’-TCCTTTGGGTTTGCAACGGATTGT-3’ (reverse), 
and human aggrecan (357 bp): 5’-CTACGACGCCATCT-
GCTACA-3’ (forward) and 5’-ACGAGGTCCTCACTGGT-
GAA-3’ (reverse). As a control group, a pellet was cultured 
with the standard medium throughout the experiment. 
Statistics
Data are presented as mean (SD). The paired t-test was used 
to assess calcium deposition and the Tukey-Kramer method 
for post-hoc testing was used to evaluate the differences in 
SDF1 plasma levels and the frequency of CXCR4 positive 
cells. Any p-value of < 0.05 was considered to be statistically 
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Results
Immunophenotyping of cells by flow cytometry
Figure 1 shows the cell-surface antigen profiles of drainage 
fluid. The frequency of CXCR4-positive cells in the MNC 
fraction (on the day of surgery and the day after surgery in 
the drainage fluid) was statistically significantly increased in 
comparison to that in the peripheral blood and bone marrow. 
The frequency of CXCR4-positive cells was increased most 
on the day after surgery, and it was significantly increased in 
comparison to that in peripheral blood and bone marrow, and 
to that in the drainage fluid on the second day after surgery.
Enzyme-linked immunosorbent assay for SDF1
The levels of SDF1 in the closed suction drainage fluid sta-
tistically were significantly elevated on the day of surgery in 
comparison to 2 days after surgery, and they were increased 
the most in the bone marrow (Figure 2).
CFU-F assay
Table 1 shows the sample volume and the concentration and 
number of MSCs in the closed suction drainage fluid on the 
day of surgery, the next day, and 2 days after surgery. The 
MNCs obtained on the day of surgery gave rise to colonies 
showing a fibroblast-like spindle shape and these colonies 
resembled CFU-Fs (Castro-Malaspina et al. 1980). Culture of 
the MNCs for 3 weeks yielded 16 (5.2) CFU-Fs in the culture 
of MNCs from the day of surgery. In contrast, no adherent 
fibroblast-like cells or colonies could be detected in the cul-
tures of the cells isolated from peripheral blood, or from the 
fluid collected on the next day or 2 days after surgery (Table 
2, Figure 3a and b). 
Figure 1. (a) Immunophenotyping results from a representa-
tive donor. Immunophenotyping of cells was confined to gated 
MNCs. Samples were stained with a combination of CD45-
FITC, CD34-PE, and CXCR4-APC monoclonal antibodies. 
(Upper: the day of surgery; middle: the day after surgery: lower: 
2 days after surgery). (b) The frequency of CXCR4-positive 
cells in MNCs was 11% (10) in peripheral blood; 13% (13) in 
bone marrow; and 38% (20), 50% (26), and 25% (22) in drain-
age fluid on the day of surgery (p.o.0 day), the next day (p.o.1 
day), and 2 days after surgery (p.o.2 day).
















Figure 2. SDF1 plasma levels in the closed suction drainage fluid were 
1,766 pg/mL (554), 942 pg/mL (574), and 828 pg/mL (460) on the day 
of surgery (p.o.0 day), the next day (p.o.1 day), and on day 2 after sur-
gery (p.o.2 day). In peripheral blood and bone marrow, the SDF1 levels 
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Differentiation
Adherent MNCs were cultured under conditions favorable for 
osteogenic and chondrogenic differentiation. After 3 weeks 
of incubation under osteogenic conditions, the colonies were 
stained with alizarin red S to examine calcification (Figure 
4a). Calcium deposition under osteogenic conditions was sta-
tistically significantly increased in comparison to that in cells 
cultured in standard medium (Figure 4b). 
After 3 weeks of incubation under chondrogenic condi-
tions, the cultured pellet stained positively with safranin O, 
but negatively after culture in the standard medium (Figure 
4c). Expression of type-II collagen and aggrecan RNA was 
also detected under chondrogenic conditions, but it was not 
detected in the standard medium by RT-PCR (Figure 4d).
Table 1. MNCs in closed suction drainage fluid (n = 5). Mean (SD)
Days after  Sample  MNC  Number of
surgery  volume concentration  MNCs
  (mL)  (× 104/mL)  (× 106)
0  300 (85)  11    (13)  30    (33)
1  150 (72)    4.9 (4.0)    7.3 (7.6)
2    51 (37)    6.8 (7.2)    2.4 (2.1)
Table 2. CFU-F numbers for each sample, after approximately 3 
weeks of culture (n = 10)
Sample  From  From From  From From
no.  day 0  day 1  day 2  PB  BM
1  9  0  0  0 18
2  17  0  0  0 19
3  14  0  0  0 20
4  20  0  0  0 35
5  11  0  0  0 25
6  27  0  0  0 28
7  12  0 0   
8  17  0 0   
9  13  0 0   
10  21  0 0
PB: peripheral blood; BM: bone marrow. 
Figure 3. After culture, the MNCs from the day of surgery gave rise to 
colonies containing cells with a fibroblast-like spindle shape and these 
colonies resembled CFU-Fs. (a) 1×. (b) 20×. Bar represents 200 µm.
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Figure 4. (a) Alizarin red S staining after 21 days of incubation in osteo-
genic medium (n = 4). (b) The calcium deposition assay showed the 
level to be 1.9 µg/mL (0.2) in cells cultured under osteogenic conditions 
and 0.13 µg/mL (0.04) in cells cultured in standard medium. (c) Safra-
nin O staining (upper: chondrogenic medium; lower: standard medium) 
(n = 2). (d) RT-PCR analysis of RNA expression of the chondrocyte-
specific genes encoding type-II collagen and aggrecan after 21 days of 
incubation (upper panel: chondrogenic medium; lower panel: standard 
medium) (n = 2).Acta Orthopaedica 2011; 82 (2): 217–222  221
Discussion
The identification of a feasible source of cells remains a chal-
lenge for tissue-engineering strategies (Pittenger et al. 1999, 
Lee et al. 2000, De Bari et al. 2001, Jones et al. 2002, Gimble 
et al. 2007). We found that osteogenic and chondrogenic pro-
genitor cells could be isolated from the closed suction drain-
age fluid after THA. In the presence of lineage-specific induc-
tion factors, the adherent cells could differentiate in vitro into 
osteogenic and chondrogenic cells. However, the adherent 
cells were obtained only during the early phase after surgery. 
These cells included a cell population that has previously been 
described as CFU-F, which has the ability to adhere to tissue 
culture plastic and proliferate to form a colony composed of 
the progeny of these founding cells (Ceradini et al. 2004). 
When the progeny of these progenitor cells are expanded in 
vitro, they show the same morphology as CFU-Fs derived 
from human bone marrow.
Recently, novel techniques such as MSC-mediated repair 
and tissue-engineered bone, ligament, meniscus, and cartilage 
have been demonstrated (Ohgushi et al. 1989, Bruder et al. 
1994, Caplan et al. 1997, Quarto et al. 2001, Buma et al. 2004, 
Ouyang et al. 2004, Van Eijk et al. 2004, Warnke et al. 2004, 
Ranieri et al. 2007, Veronique et al. 2007). A stem/progenitor 
cell fraction from drainage fluid from arthroplasties could be 
used for postoperative problems such as fractures or revision 
surgery with bone loss.
The closed suction drainage fluid after hip arthroplasty has 
direct access to the bone marrow. Thus, multilineage-poten-
tial cells (MPCs) can be recruited from the bone marrow. The 
other possibility is that MPCs may be derived from circu-
lating MPCs. Recently, considerable attention has been paid 
to the role of accumulating stem/progenitor cells in injured 
tissue such as thrombus, ischemic zones, and sites of arte-
rial injury (Peled et al. 1999, Weber et al. 2004, Modarai et 
al 2005). These cells may be involved in tissue repair after 
surgery. Many authors have suggested that the SDF1/CXCR4 
axis plays an essential role in mobilization and homing of 
stem/progenitor cells (Aiuti et al. 1997, Peled et al. 1999, 
Ceradini et al. 2004, Kucia et al. 2005). SDF1 is produced in 
response to tissue damage and plays an important role in the 
mobilization of CXCR4 positive cells. Several cell types such 
as cardiomyocytes, muscle-derived fibroblasts, and endothe-
lial cells secrete SDF1. In addition, ischemia and hypoxia can 
induce SDF1 expression. In the present study, the SDF1 level 
was found to be increased on the day of surgery and expres-
sion of CXCR4 was elevated in the closed suction drainage 
fluid on the day of surgery and on the following day. This 
may indicate that locally induced SDF1 levels contribute 
to the mobilization of circulating CXCR4-positive cells to 
the injured sites, although direct proof will require further 
research.
In summary, closed suction drainage fluid on the day of 
THA contains multipotent stem/progenitor cells that could be 
expanded by culture in vitro and induced to differentiate via 
the osteogenic and chondrogenic pathway. 
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